| GWAS |
- Alzheimer's disease ( 34099642
)
- Cerebrospinal fluid α-synuclein levels ( 29959729
)
- Glaucoma (primary open-angle) ( 33627673
)
- HDL cholesterol levels in HIV infection ( 33109212
)
- Longitudinal change in brain amyloid plaque burden ( 26268530
)
- Spatial processing ( 31596458
)
|
- Adult body size ( 32376654
)
- Attention deficit hyperactivity disorder (inattention symptoms) ( 32595297
)
- Bipolar disorder (body mass index interaction) ( 24322204
)
- Body mass index ( 25673413
)
- Bone ultrasound measurement (broadband ultrasound attenuation) ( 28472463
)
- Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia ( 29274321
)
- Chronic bronchitis and chronic obstructive pulmonary disease ( 25241909
)
- Chronic mountain sickness ( 31417607
)
- Cognitive performance ( 20125193
)
- Copper levels ( 26025379
)
- Diastolic blood pressure ( 27841878
)
- Drug-induced liver injury (flucloxacillin) ( 19483685
)
- Electrocardiogram morphology (amplitude at temporal datapoints) ( 32916098
)
- Heart rate increase in response to exercise ( 29497042
)
- Heart rate response to exercise ( 29769521
)
- Heart rate response to recovery post exercise ( 29769521
)
- Heart rate response to recovery post exercise (50 sec) ( 29497042
)
- Hippocampal volume ( 25625606
)
- Homeostasis model assessment of insulin resistance ( 33381925
)
- Motion sickness ( 25628336
)
- Neonatal cytokine/chemokine levels (maternal genetic effect) ( 30134952
)
- Night sleep phenotypes ( 27126917
)
- Overweight status ( 25133637
)
- Parkinson's disease progression (composite) ( 33111402
)
- Parkinson's disease progression (motor) ( 33111402
)
- Refractive error ( 32231278
)
- Response to mTOR inhibitor (rapamycin) ( 24009623
)
- Serum alkaline phosphatase levels ( 33547301
)
- Stearic acid (18:0) levels ( 23362303
)
- Sudden cardiac arrest ( 21658281
)
- Trunk fat mass ( 28552196
)
- Type 1 diabetes nephropathy ( 23028342
)
- White matter hyperintensity burden ( 25663218
)
|
